GlassScriptPhysician profile
Rekha Kesavan
NPI 1497908560
$4,748.02
in general payments reported to CMS, 2019-2025
35 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $49.86 · 2021: $482 · 2022: $1,139 · 2023: $1,062 · 2024: $999 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,053 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,052.99 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,802.30 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $372.80 | 2020-2024 | Mounjaro, Zepbound, Jardiance |
| Shield Therapeutics INC | $335.46 | 2022-2025 | Accrufer |
| Amgen INC. | $208.67 | 2024-2025 | Repatha, Krystexxa, Otezla |
| Astellas Pharma US INC | $198.30 | 2023-2025 | Veozah, Myrbetriq |
| Abbott Laboratories | $177.88 | 2023-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $177.72 | 2021-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $150.43 | 2024-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $131.38 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.74 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Pfizer INC. | $93.14 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $90.88 | 2024-2025 | Airsupra, Farxiga |
| Currax Pharmaceuticals LLC | $83.55 | 2022-2025 | Contrave, Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $76.82 | 2021-2023 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $76.27 | 2023-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $75.89 | 2024 | Interstim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $65.49 | 2023-2025 | Xifaxan, Trulance |
| Horizon Therapeutics Plc | $57.94 | 2023 | Krystexxa |
| Exact Sciences Corporation | $53.31 | 2023-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $51.27 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Bardy Diagnostics, INC. | $45.33 | 2022 | |
| Novartis Pharmaceuticals Corporation | $44.59 | 2022-2023 | |
| Optos, INC. | $36.57 | 2020 | |
| Corcept Therapeutics | $29.10 | 2025 | Korlym |
| Silk Road Medical, INC. | $28.18 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Linus Health, INC. | $26.91 | 2022-2024 | Core Cognitive Evaluation |
| Genzyme Corporation | $21.95 | 2022 | |
| Paratek Pharmaceuticals, INC. | $21.75 | 2022 | |
| Biomerieux INC | $18.00 | 2025 | |
| Vital Connect, INC | $17.58 | 2025 | Vitalpatch Rtm |
| Actelion Pharmaceuticals US, INC. | $17.34 | 2024 | Uptravi, Opsumit |
| Seqirus USA INC | $16.17 | 2025 | Flucelvax, Fluad |
| Phadia US INC. | $15.95 | 2023 | Immunocap |
| Alexion Pharmaceuticals, INC. | $13.56 | 2021 | |
| Lucid Diagnostics INC. | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rekha Kesavan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.